|
|
Volumn 1, Issue 1, 2002, Pages 11-12
|
|
Antiviral market overview. Market indicators
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
ANTIVIRUS AGENT;
4 [(4 BROMOPHENYL)(ETHOXYIMINO)METHYL] 1' [(2,4 DIMETHYL 3 PYRIDINYL)CARBONYL] 4' METHYL 1,4' BIPIPERIDINE;
ABACAVIR PLUS LAMIVUDINE PLUS ZIDOVUDINE;
ALPHA INTERFERON;
AMPRENAVIR PHOSPHATE;
ANTIRETROVIRUS AGENT;
ATAZANAVIR;
CAPRAVIRINE;
CD4 IMMUNOGLOBULIN G2;
DAPIVIRINE;
DIDANOSINE;
EMIVIRINE;
EMTRICITABINE;
ENFUVIRTIDE;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
INDINAVIR;
INTEGRASE INHIBITOR;
LOPINAVIR PLUS RITONAVIR;
MOZENAVIR;
NELFINAVIR;
NUCLEOSIDE ANALOG;
PROTEINASE INHIBITOR;
RECEPTOR BLOCKING AGENT;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
T 1249;
TIPRANAVIR;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VIRUS VACCINE;
ZALCITABINE;
ZIDOVUDINE;
ANTIBIOTIC RESISTANCE;
ARTICLE;
DRUG INDUSTRY;
HUMAN;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
CLINICAL TRIAL;
DRUG CLASSIFICATION;
DRUG EFFICACY;
DRUG MARKETING;
DRUG MECHANISM;
HEPATITIS C;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LIFE EXPECTANCY;
NOTE;
PATIENT COMPLIANCE;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
SIDE EFFECT;
TREATMENT FAILURE;
VIRUS LOAD;
VIRUS RESISTANCE;
WORLD HEALTH ORGANIZATION;
ANTI-HIV AGENTS;
ANTIVIRAL AGENTS;
DRUG INDUSTRY;
DRUG RESISTANCE, VIRAL;
HUMANS;
|
|
EID: 0036051991
PISSN: 14741776
EISSN: None
Source Type: Journal
DOI: 10.1038/nrd709 Document Type: Note |
|
Times cited : (6)
|
|
References (0)
|
